MDMing Du

Ming Du

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ming Du has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potentials and Applications of Microalgae and Spirulina (Cyanobacterium) in Pet Nutrition and Health: A Comprehensive Review with a Special Focus on Euglena gracilis

    by Jing Liu, Leshi Li, Yan Yan, Ming Du, Jiangxin Wang

    The pet food industry is undergoing a significant transformation, driven by the growing trend of companion animal humanization and increasing concerns over the environmental sustainability of conventional protein and lipid sources. Consumers now seek diets that not only meet basic nutritional requirements but also offer preventive health benefits. Microalgae, including Arthrospira (Spirulina, a kind of cyanobacterium), Chlorella, Schizochytrium, and Euglena gracilis, have emerged as versatile biological platforms capable of addressing both functional and sustainability challenges. These microorganisms produce high-quality proteins, omega-3 long-chain polyunsaturated fatty acids (particularly docosahexaenoic acid, DHA), natural pigments, and immunomodulatory polysaccharides. This review synthesizes findings from peer-reviewed studies on the application of microalgae in pet nutrition, covering dogs, cats, and aquatic companion animals. We examine how algal ingredients influence gut microbiota, for instance, by enriching beneficial genera such as Turicibacter and Peptococcus, enhance vaccine responses and mucosal immunity, support cognitive function in aging pets, and contribute to weight management. Particular attention is given to Euglena gracilis and its paramylon (β-1,3-glucan), a pathogen-associated molecular pattern that engages the Dectin-1 pathway to train innate immunity and has demonstrated antiviral activity through host defense mechanisms. The review also surveys the patent landscape, highlighting trends in palatability enhancement, hypoallergenic formulations, and novel delivery formats. Key challenges remain, including ingredient standardization, safety validation, palatability optimization, and consumer acceptance. We outline a translational roadmap that prioritizes well-designed clinical trials in target species and processing methods that preserve bioactivity. Collectively, the evidence positions microalgae, and Euglena gracilis in particular, as promising candidates for next-generation functional pet foods that deliver health benefits alongside ecological sustainability.

  • Integrated nutrient removal and biodiesel potential of newly isolated Desmodesmus sp. F1 and Scenedesmus sp. Fs from synthetic municipal wastewater

    by Chao Li, Zhaoyi Li, Ming Du, Youping Nan, Helen Yu, Jiangxin Wang

    Microalgae have demonstrated significant potential in sustainable wastewater treatment and biofuel production due to their ability to efficiently remove nutrients while generating high-value biomass. In this study, we isolated and identified two dual-functional microalgae, Desmodesmus sp. F1 and Scenedesmus sp. Fs, which exhibited better growth and higher pollutant removal efficiencies in synthetic municipal wastewater compared to Chlorella vulgaris. F1 and Fs achieved rapid nitrogen (N) and phosphorus (P) removal, with total nitrogen removal exceeding 96% and nearly 100% of phosphorus removed within 72 h. The two strains exhibited strong lipid accumulation, with lipid content exceeding 55% of dry weight, positioning them as promising candidates for biodiesel production. Comparatively, F1 exhibited a balanced fatty acid profile and favorable cetane number, making it suitable for high-quality biodiesel. This performance surpasses other studied strains such as Chlorella vulgaris and Scenedesmus obliquus, positioning F1 and Fs as viable candidates for integrated environmental remediation and biofuel applications. These findings provide insights for future optimizing microalgae-based systems for sustainable wastewater treatment and bioenergy production, highlighting the potential of F1 and Fs for scalable environmental and energy applications.

  • Open Access

    Microalgae-Derived Bioactive Compounds for Liver Health: Mechanisms, Therapeutic Potential, and Translational Challenges

    by Wentao Sun, Ming Du, Guoming Shen, Dongming Lai, Jiangxin Wang

    Microalgae are sustainable sources of bioactive compounds with broad hepato-protective potential. This review synthesizes evidence for five major classes—carotenoids such as astaxanthin and fucoxanthin, polysaccharides such as paramylon and fucoidan, phycobiliproteins such as phycocyanin, omega-3 fatty acids, and phenolic extracts—linking their actions to key liver injury mechanisms. Preclinically, these compounds enhance antioxidant defenses, improve mitochondrial function, suppress inflammatory signaling, regulate lipid metabolism, modulate the gut–liver axis, and inhibit hepatic stellate cell activation, thereby attenuating fibrosis. Consistent benefits are observed in models of non-alcoholic and alcoholic fatty liver disease, drug-induced injury, ischemia–reperfusion, and fibrosis, with marked improvements in liver enzymes, oxidative stress, inflammation, steatosis, and collagen deposition. Emerging evidence also highlights their roles in regulating endoplasmic reticulum stress and ferroptosis. Despite their promise, translational challenges include compositional variability, a lack of standardized quality control, limited safety data, and few rigorous human trials. To address these challenges, we propose a framework integrating multi-omics and AI-assisted strain selection with specification-driven quality control and formulation-aware designs—such as lipid carriers for carotenoids or rational combinations like fucoxanthin with low-molecular-weight fucoidan. Future priorities include composition-defined randomized controlled trials in non-alcoholic fatty liver disease, alcoholic liver disease, and drug-induced liver injury; harmonized material specifications; and multi-constituent interventions that synergistically target oxidative, inflammatory, metabolic, and fibrotic pathways.